Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Using nutraceuticals in the management of major depressive disorder (MDD)

Using nutraceuticals in the management of major depressive disorder (MDD) PurposeThe purpose of this paper is to study evidence-based records on the impact of some effective nutraceuticals on major depression disorder management; and describe the antidepressant properties of nutraceuticals to achieve health policy targets and maintain a sustainable healthcare system.Design/methodology/approachThe literature was searched using MEDLINE (PubMed), Google Scholar, PsycINFO and Quertile databases and retrieving relevant published articles in peer-reviewed journals.FindingsThe results provided evidence of a range of nutraceuticals with potential benefits in the management of depression. Studies support the anti-depressant properties of S-adenosyl methionine, folnic acid, 5-hydroxytryptophan and omega-3 fatty acids. The results might represent evidence for an innovative adjunctive neurobiological line for the management and treatment of depression.Practical implicationsRandomized-controlled trials and evaluations continue to provide evidence for the use of nutraceuticals in the treatment of depression.Social implicationsNutraceuticals emphasize the personalized medicine, which offers a psychophysical balance to the individual.Originality/valueNutraceuticals have specific antidepressant properties that may be beneficial in psychiatric populations and reduce pharmacotherapeutic side effects. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png World Journal of Science, Technology and Sustainable Development Emerald Publishing

Using nutraceuticals in the management of major depressive disorder (MDD)

Loading next page...
 
/lp/emerald-publishing/using-nutraceuticals-in-the-management-of-major-depressive-disorder-BaTehLtOlX
Publisher
Emerald Publishing
Copyright
Copyright © Emerald Group Publishing Limited
ISSN
2042-5945
DOI
10.1108/WJSTSD-01-2016-0007
Publisher site
See Article on Publisher Site

Abstract

PurposeThe purpose of this paper is to study evidence-based records on the impact of some effective nutraceuticals on major depression disorder management; and describe the antidepressant properties of nutraceuticals to achieve health policy targets and maintain a sustainable healthcare system.Design/methodology/approachThe literature was searched using MEDLINE (PubMed), Google Scholar, PsycINFO and Quertile databases and retrieving relevant published articles in peer-reviewed journals.FindingsThe results provided evidence of a range of nutraceuticals with potential benefits in the management of depression. Studies support the anti-depressant properties of S-adenosyl methionine, folnic acid, 5-hydroxytryptophan and omega-3 fatty acids. The results might represent evidence for an innovative adjunctive neurobiological line for the management and treatment of depression.Practical implicationsRandomized-controlled trials and evaluations continue to provide evidence for the use of nutraceuticals in the treatment of depression.Social implicationsNutraceuticals emphasize the personalized medicine, which offers a psychophysical balance to the individual.Originality/valueNutraceuticals have specific antidepressant properties that may be beneficial in psychiatric populations and reduce pharmacotherapeutic side effects.

Journal

World Journal of Science, Technology and Sustainable DevelopmentEmerald Publishing

Published: Jan 7, 2017

References